President Donald Trump called on the Food and Drug Administration to “move quickly” on coronavirus vaccines, following Johnson & Johnson’s announcement its candidate has reached a final-stage trial.
Johnson & Johnson announced it has begun dosing up to 60,000 volunteers in a study of its Covid-19 vaccine, the first major U.S. trial of a shot that may work after just one dose. The vaccine candidate joins three others in late-stage trials in the U.S., amid the administration’s Operation Warp Speed push to develop and distribute an inoculation by year’s end.
If the company can enroll enough participants, the trial could yield results as soon as the end of 2020, which could allow the company to seek emergency authorization early next year if the vaccine proves effective, Johnson & Johnson Chief Scientific Officer Paul Stoffels said Tuesday.
Read more at NEWSMAX.